EICHOR
● Completed
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
Condition: PAH · Pulmonary Hypertension · Pulmonary Arterial Hypertension · Sponsor: United Therapeutics
About this study
Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (209)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| University of Arizona | Tucson, Arizona, United States | — |
| UCSD Health Sciences | La Jolla, California, United States | — |
| Loma Linda University Medical Center | Loma Linda, California, United States | — |
| Ronald Reagan UCLA Medical Center | Los Angeles, California, United States | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles, California, United States | — |
| Keck Hospital of USC | Los Angeles, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| VA Greater Los Angeles Healthcare System | Los Angeles, California, United States | — |
| University of California, Irvine | Orange, California, United States | — |
| University of California Davis Medical Center | Sacramento, California, United States | — |
+ 197 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03626688